It has decades of safety data
There is, however, a possibility that BPC 157 may not be right for everyone
In addition, a small pilot safety study published in Alternative Therapies in Health and Medicine showed that intravenous infusions of BPC-157 up to 20 milligrams were well-tolerated with no reported adverse effects in healthy adults, providing initial evidence that the peptide can be administered safely, a necessary step before larger efficacy trials on healing outcomes are conducted
Some products may include additional storage guidance
However, the best peptide depends on individual health status and medical supervision
Its also essential to note that while a B12 deficiency may contribute to cognitive decline, it is not the sole cause of dementia, Dr